Adverse events related to alpha-blockers: analysis of real-life data from Eudra-Vigilance.

Author: BaldassarriValeria, CicioneAntonio, D'AnnunzioSimone, DE NunzioCosimo, FrancoAntonio, GuarnottaGiorgio, LombardoRiccardo, ManciniElisa, NacchiaAntonio, RovestiLorenzo M, TemaGiorgia, TubaroAndrea, VoglinoOlivia A

Paper Details 
Original Abstract of the Article :
BACKGROUND: Patients on alpha-blockers (ABs) treatment may have an increased risk of adverse events (AEs). Aim of our study was to compare real-life data on neuro-vascular and sexual AEs associated with ABs based on Eudra-Vigilance reported AEs. METHODS: Eudra-Vigilance (EV) database is the system ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.23736/S2724-6051.23.05225-4

データ提供:米国国立医学図書館(NLM)

Alpha-Blockers - A Closer Look at Adverse Events

This study analyzes real-life data from Eudra-Vigilance, a system for managing and analyzing suspected adverse reactions to medicines, to compare the risks of adverse events (AEs) associated with different alpha-blockers (ABs). The study finds that certain ABs, like silodosin, are associated with a higher risk of ejaculatory disorders, while others, like tamsulosin, are associated with a lower risk of orthostatic hypotension. This research provides valuable information for clinicians to consider when prescribing ABs.

Navigating the Risks: Alpha-Blockers and Patient Safety

The study reveals that the risks associated with different ABs can vary significantly. This information is crucial for clinicians to consider when prescribing these medications, ensuring that patients are aware of the potential risks and benefits.

Informed Decision-Making: Alpha-Blockers and Personalized Care

This research highlights the importance of personalized care when prescribing medications. Understanding the specific risks and benefits of different ABs can help clinicians make informed decisions about treatment, ensuring that patients receive the most appropriate and safe care.

Dr. Camel's Conclusion

Just as a camel navigates a diverse and challenging desert landscape, clinicians navigate the complex world of medication choices. This study provides valuable insights into the risks associated with different alpha-blockers, reminding us that every medication comes with potential benefits and risks. This research underscores the importance of careful consideration and individualized treatment strategies to ensure patient safety and optimal health outcomes.
Date :
  1. Date Completed 2023-08-03
  2. Date Revised 2023-08-03
Further Info :

Pubmed ID

37067186

DOI: Digital Object Identifier

10.23736/S2724-6051.23.05225-4

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.